Ahmad Besaratinia, PhD

Professor of Research Population and Public Health Sciences

Image of Ahmad Besaratinia, PhD
Is this your profile? Click to edit

Overview

Dr. Besaratinia’s research focuses on the molecular causes and mechanistic underpinning of human disease. His laboratory investigates the role of genetics and epigenetics in the development of a wide variety of diseases, including cancer at multiple organ sites, cardiovascular-, respiratory-, immune-related (inflammatory), and metabolic diseases. Emphasis is placed on genetic mechanisms (e.g., DNA damage & repair and mutagenesis) and epigenetic mechanisms (e.g., DNA methylation, histone modifications, and non-coding RNA dysregulation). Of special interest are chronic diseases with modifiable risk factors, including lifestyle, diet, and occupational/medicinal/environmental determinants. A primary focus of research is tobacco-related diseases and the health risks associated with the use of new and emerging tobacco products, e.g., electronic cigarettes (e-cigs | vapes) and oral nicotine pouches (ONP). Dr. Besaratinia’s group conducts human subject research involving the general population, at-risk populations, or disease cohorts, complemented with experimental studies in laboratory animals or cell culture models. His team uses a combination of classic molecular biology techniques and cutting-edge ‘omics’ technologies to detect alterations in the genome, epigenome, transcriptome, and proteome in cells and tissues of humans/experimental animals/cultures exposed to known or suspected disease-causing agents. Systems biology approaches are then deployed to integrate the results in order to elucidate how the interplay of genetic, epigenetic, transcriptomic, and proteomic changes contributes to the development of diseases. The ultimate goal is to develop molecular markers, otherwise known as ‘biomarkers’, that can be used for prevention, early detection, treatment, and monitoring of the progression of diseases.

Research Funding

  • Network-based analysis of disease-associated epigenetic changes in youth electronic cigarette users
    NIH · R21DA058342 · Sep 1, 2023 – Aug 31, 2025 · Role: Principal Investigator
  • Differentiating the biological effects of vaping from smoking by analyzing the methylome and transcriptome
    NIH · R01DE031863 · Aug 15, 2023 – May 31, 2028 · Role: Principal Investigator
  • Development of biomarkers of exposure and effects for electronic cigarette vs. combustible cigarette use
    NIH/NCI · 1R21CA268197 · Sep 23, 2021 – Aug 31, 2024 · Role: Principal Investigator
  • Genetic epigenetic & transcripotomic effects of e-cig aerosol on oral epithelium
    NIH/NIDCR · R01DE026043 · Mar 3, 2016 – Feb 28, 2021 · Role: Principal Investigator
  • Development of biomarkers of secondhand smoke genotoxicity
    American Cancer Society (ACS) · Jan 1, 2011 – Jan 31, 2016 · Role: Principal Investigator

Research Keywords

  • Cancer biology
  • Cancer genetics
  • Epigenetics
  • Public health
  • Tobacco control and prevention
  • Electronic Nicotine Delivery Systems (ENDS): Electronic cigarettes (e-cigs)
  • Environmental carcinogenesis
  • Melanoma research

Media

Publications

  • Oral nicotine pouches: Rising popularity of a new class of tobacco products among youth. Public Health. 2026 Sep; 258:106412.. View in PubMed
  • Multidimensional exposure architecture shapes vaping-associated transcriptomic dysregulation in oral epithelium. Front Oncol. 2026; 16:1838256.. View in PubMed
  • Long noncoding RNAs at the crossroads of smoking, oxidative stress, inflammation, and lung disease. Arch Toxicol. 2026 May; 100(5):1789-1823.. View in PubMed
  • Electronic Cigarette-Derived Metals: Exposure and Health Risks in Vapers. Chem Res Toxicol. 2025 Apr 21; 38(4):542-556.. View in PubMed
  • Epigenomic Dysregulation in Youth Vapers: Implications for Disease Risk Assessment. Am J Respir Cell Mol Biol. 2025 02; 72(2):206-218.. View in PubMed
  • The interplay of DNA damage and repair, gene expression, and mutagenesis in mammalian cells during oxidative stress. Carcinogenesis. 2024 11 22; 45(11):868-879.. View in PubMed
  • The Untapped Biomarker Potential of MicroRNAs for Health Risk-Benefit Analysis of Vaping vs. Smoking. Cells. 2024 08 10; 13(16).. View in PubMed
  • Exploring the Utility of Long Non-Coding RNAs for Assessing the Health Consequences of Vaping. Int J Mol Sci. 2024 Aug 05; 25(15).. View in PubMed
  • Vaping Dose, Device Type, and E-Liquid Flavor are Determinants of DNA Damage in Electronic Cigarette Users. Nicotine Tob Res. 2023 05 22; 25(6):1145-1154.. View in PubMed
  • The State of Research and Weight of Evidence on the Epigenetic Effects of Bisphenol A. Int J Mol Sci. 2023 Apr 27; 24(9).. View in PubMed